とし
liked
Pfizer (NYSE: PFE) announced on Wednesday that the experimental gene therapy drug giroctocogene fitelparvovec, jointly developed with Sangamo Therapeutics (NASDAQ: SGMO), has achieved major and major secondary goals in late-stage clinical trials targeting adult hemophilia A.
Citing top-line data from the phase 3 AFFINE trial, the company stated that the diloctocogene fitelparvovec achieved its main goal compared to routine preventive therapy for hemophilia A, a bleeding disorder characterized by a deficiency of blood clotting proteins called blood coagulation factor VIII.
According to PFE, this trial for adult patients with moderate to severe hemophilia A achieved the main goals of non-inferiority and superiority for factor VIII replacement prophylactic therapy based on annual rate converted bleeding rates from week 12 to at least 15 months after infusion.
Regarding safety, the tolerability of girotocogen fitelparvovec was generally good. However, serious adverse events were observed in 20% of study participants, of which 13% were treatment-related...
Citing top-line data from the phase 3 AFFINE trial, the company stated that the diloctocogene fitelparvovec achieved its main goal compared to routine preventive therapy for hemophilia A, a bleeding disorder characterized by a deficiency of blood clotting proteins called blood coagulation factor VIII.
According to PFE, this trial for adult patients with moderate to severe hemophilia A achieved the main goals of non-inferiority and superiority for factor VIII replacement prophylactic therapy based on annual rate converted bleeding rates from week 12 to at least 15 months after infusion.
Regarding safety, the tolerability of girotocogen fitelparvovec was generally good. However, serious adverse events were observed in 20% of study participants, of which 13% were treatment-related...
Translated
8
とし
liked
$Maxeon Solar Technologies (MAXN.US)$
I will hold on to it because I want to see the short sellers here cry.
I will hold on to it because I want to see the short sellers here cry.
Translated
6
1
とし
liked
Lower-than-expected inflationIt was announced, and expectations were raised that the US Federal Reserve (Fed) would start cutting interest rates at an early stage, and stock prices of companies related to solar power generation and alternative energy rose widely.
Solar-related stocks are Sanova Energy (NOVA) +19% and sun run (RUN) +15.4%, Maxeon Solar (MAXN) +14.2%, Array Technologies (ARRY) +9.3%, emelene (SOL) +8.9%, Canadian Solar (CSIQ) +7.9%, Sunpower (SPWR) +7.1%, Enphase Energy (NASDAQ:ENPH) +4.6%, Jinko Solar (JKS) +4%, Fast Solar (FSLR) +2.1%, etc.
Other clean energy-related brands include stem (STEM) +11.3%, Clean Energy Fuels (CLNE) +8.9%, plug power (PLUG) +8.9%, Fuel Cell Energy (FCEL) +8.1%, TPI composite (TPIC) +6.4%, Fluence Energy (FLNC) +5.5%, Westport F...
Solar-related stocks are Sanova Energy (NOVA) +19% and sun run (RUN) +15.4%, Maxeon Solar (MAXN) +14.2%, Array Technologies (ARRY) +9.3%, emelene (SOL) +8.9%, Canadian Solar (CSIQ) +7.9%, Sunpower (SPWR) +7.1%, Enphase Energy (NASDAQ:ENPH) +4.6%, Jinko Solar (JKS) +4%, Fast Solar (FSLR) +2.1%, etc.
Other clean energy-related brands include stem (STEM) +11.3%, Clean Energy Fuels (CLNE) +8.9%, plug power (PLUG) +8.9%, Fuel Cell Energy (FCEL) +8.1%, TPI composite (TPIC) +6.4%, Fluence Energy (FLNC) +5.5%, Westport F...
Translated
4
とし
liked
Seems to be skyrocketing, right?
This volume is attracting attention nationwide.
Participating in MAXN carnival.
This volume is attracting attention nationwide.
Participating in MAXN carnival.
Translated
10
とし
reacted to
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)